Cadaver Musculoskeletal Anatomy EMG/MSKUS Guided Injections, Dystonia and Spasticity

Needs Statement

The educational needs of learners has grown as we recover from the pandemic. Learners have not had the opportunity for hands on cadaver training. Thus, combined virtual lectures bringing in outside speakers and in person cadaver lab with distinguished speakers will be arranged. Cadaver prosectional anatomy will be reviewed and injection skills check on cadavers will be carried out with learners.

This course will address both the educational gap for PMR residents and fellows to learn more about recognition and treatment of cervical dystonia and upper and lower limb spasticity with chemodenervation. An educational series is envisioned at this time to optimize their clinical educational experience.

Educational Objectives

At the conclusion of the conference, participants should be able to:

• Describe the musculoskeletal anatomy of the neck, arm and leg as it relates to limb spasticity injection
• Describe two types of guided injections that can be used for spasticity/dystonia
• Describe suspension and injection strategies for botulinum toxin.
• Name and demonstrate how to inject at least two of the 8 new muscles FDA approved for spasticity injection

Target Audience

Accreditation/Credit Designation

Physician

Baylor College of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

 Baylor College of Medicine designates this live activity for a maximum of 8.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Disclosure Policy

Baylor College of Medicine (BCM) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education (CME) for physicians. BCM is committed to sponsoring CE activities that are scientifically based, accurate, current, and objectively presented.

In accordance with the ACCME Standards for Commercial Support, BCM has implemented a mechanism requiring everyone in a position to control the content of an educational activity (i.e., directors, planning committee members, faculty) to disclose any relevant financial relationships with commercial interests (drug/device companies) and manage/resolve any conflicts of interest prior to the activity. Individuals must disclose to participants the existence or non-existence of financial relationships at the time of the activity or within 24 months prior.

In addition, BCM has requested activity faculty/presenters to disclose to participants any unlabeled use or investigational use of pharmaceutical/device products; to use scientific or generic names (not trade names) in referring to products; and, if necessary to use a trade name, to use the names of similar products or those within a class. Faculty/presenters have also been requested to adhere to the ACCME's validation of clinical content statements.

BCM does not view the existence of financial relationships with commercial interests as implying bias or decreasing the value of a presentation. It is up to participants to determine whether the relationships influence the activity faculty with regard to exposition or conclusions. If at any time during this activity you feel that there has been commercial/promotional bias, notify the Activity Director or Activity Coordinator. Please answer the questions about balance and objectivity in the activity evaluation candidly.

All of the relevant financial relationships listed for these individuals have been mitigated.